Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action

Get involved

Our campaigns

3 results found
There are 10 active filters
Clear all filters
Nigeria
Yemen
HIV/AIDS
antiretroviral medicines

3 results found

Dr Abdulfattah Al-Alimi Field coordinator and medical team leader of the Médecins Sans Frontières (MSF) HIV/AIDS project in Yemen

Feature story |

29 October 2015

Yemen: antiretroviral treatment beneath the bombs

Tags HIV/AIDS HIV/AIDS antiretroviral medicines Yemen

Press release |

14 December 2005

Forcing patients to pay for AIDS care endangers treatment success

Tags HIV/AIDS HIV/AIDS antiretroviral medicines Nigeria

Press release |

25 April 2001

Nigeria's Choice of Generics Will Allow 10,000 to be Treated but This Strategy May be Outlawed by New World Trade Rules

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines TRIPS Nigeria

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Yemen: antiretroviral treatment beneath the bombs

Forcing patients to pay for AIDS care endangers treatment success

Nigeria's Choice of Generics Will Allow 10,000 to be Treated but This Strategy May be Outlawed by New World Trade Rules